Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
        • Real stories
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Careers and studies
        • Contact
  • Donate
    Centenary Institute > News > New discovery may hold key to fighting deadly infections

New discovery may hold key to fighting deadly infections

Date time 12 May, 2022
News Type News type Media release
Centenary Institute research has revealed new insight into tackling mycobacterial infections which are responsible for chronic diseases that include tuberculosis (TB), leprosy and serious skin ulcerations.

Reported in the peer reviewed journal, Life Science Alliance, the research found a new way to improve host immunity by decreasing potassium levels in immune cells. Significantly, this could offer up an entirely new approach to fighting infectious diseases.

“Mycobacterial infections are caused by bacteria from the Mycobacteriaceae family,” said lead author of the study, Dr Elinor Hortle from the Centenary Institute.

“They cause significant harm and mortality to human health. With an estimated one quarter of the world’s population infected with TB, new approaches to overcoming mycobacterial infections and preventing disease are desperately needed.”

In the study, the researchers used zebrafish and human cells to explore the role of inflammasomes in fighting mycobacteria infection. Multi-protein complexes that exist inside of cells, inflammasomes, are a key part of the innate immune system. They induce inflammation to fight harmful bacteria and infection.

“Many successful pathogens, including mycobacteria, have evolved strategies to limit inflammasomes from activating, to escape the body’s immune response,” Dr Hortle said.

“We wanted to see if we could aid inflammasome activation in response to mycobacteria exposure. Boosting the immune system in this way could help in the fight against chronic bacterial diseases.”

Central to the study was potassium efflux – a process necessary for inflammasome activation to occur. It is where potassium crosses the cell membrane in response to mycobacteria or other pathogenic activity. A corresponding drop of potassium levels inside the cell triggers inflammasome activation.

Critically, the researchers found that mycobacterial infection increased levels of the enzyme OXSR1 (Oxidative Stress Responsive Kinase 1) which causes cells to hoard intracellular potassium. Inhibiting OXSR1 decreased intracellular potassium levels which in turn improved inflammasome activation and reduced mycobacterial count.

“Our findings that OXSR1 can be targeted to decrease bacterial burden defines a new avenue for therapeutic development,” said Dr Stefan Oehlers, study senior author and researcher affiliated with both the Centenary Institute and A*STAR Infectious Diseases Labs (Singapore).

“It shows that potassium pathways in the cell can be influenced by new therapeutic drugs to activate inflammasomes, to control mycobacterial infections.”

Dr Oehlers said that given mycobacteria are not the only pathogens which affect inflammasome activation, OXSR1 inhibition may be an effective therapy with broad applicability across other disease areas.

Themes

  • Inflammation

    Inflammation

People

  • Dr Elinor Hortle

    Postdoctoral Research Fellow

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw, Media and Communications Manager

Phone number Phone Number 0402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

New discovery may hold key to fighting deadly infections

Download

Recent Stories

  • ABC News interviews Professor Semsarian AM

    Professor Christopher Semsarian AM, Head of the Agnes Ginges Centre for Molecular Cardiology at the Centenary Institute and a cardiologist at Royal Prince Alfred Hospital, has provided expert commentary on the ABC, on the role of genetics in heart disease and the growing significance of DNA analysis in court proceedings. According to Professor Semsarian, advanced ...
    News Type: Media coverage
    Date 08 Jun 2023
  • New study uncovers potential therapeutic target for breast cancer

    Research conducted at the Centenary Institute has unveiled crucial insights into the underlying molecular mechanisms of breast cancer. The findings could lead to a more effective treatment for the disease, which claims the lives of over 3,000 Australian women and men annually.
    News Type: Media release
    Date 07 Jun 2023
  • TB-CRE Symposium held at the Centenary Institute

    The Centre of Research Excellence in Tuberculosis Control (TB-CRE) has held its annual symposium at the Centenary Institute, showcasing key tuberculosis (TB) research outcomes and bringing over 250 scientists together to enable TB discussion and facilitate future planning.
    News Type: Research News
    Date 05 Jun 2023
  • Study shows early changes in immune cells linked to COPD

    A new study led by the Centenary Institute and the University of Bonn has revealed new insights into the early stages of chronic obstructive pulmonary disease (COPD), a debilitating respiratory condition characterised by inflammation in the lungs and severe breathing difficulties.
    News Type: Research News
    Date 30 May 2023

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram